Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge in women of reproductive age — affecting roughly one in three women at some point. It develops when the protective lactobacillus-dominated vaginal flora is replaced by an overgrowth of anaerobic bacteria (Gardnerella vaginalis, Atopobium, Mobiluncus, and others). Classical presentation: thin grey-white discharge with characteristic fishy odour, more pronounced after intercourse. The MedsBase BV Treatment catalogue stocks the standard treatment options, supplied by WHO-GMP gecertificeerde fabrikanten.
First-line antibiotic treatment. Metronidazole is the first-line agent — either 500 mg orally twice daily for 7 days, or vaginal gel 0.75% applied at bedtime for 5 nights. Alternative: clindamycin 2% vaginal cream applied at bedtime for 7 nights, or oral clindamycin 300 mg twice daily for 7 days. Single-dose tinidazole 2 g is an alternative oral option. Browse our Antibiotica catalogue for metronidazole (Flagyl, Metroga, Metrogyl Gel), tinidazole (Tinvista, Tinima), and clindamycin (Dalacin C, Clinka Gel) options. The combination antibiotic + lactobacillus probiotic Revidox-LB may help restore protective flora after antibiotic treatment.
Topical adjuncts. Topical clotrimazole vaginal cream Candid V Gel is useful when bacterial vaginosis coexists with vaginal candidiasis (a common pattern). Combination kits including the Medische noodkit bundle relevant acute-care medications.
Hoe te gebruiken. Suspected BV with classical features (thin grey-white discharge, fishy odour, no itching/burning of typical candida) → metronidazole 500 mg BID × 7 days oral, or 0.75% vaginal gel × 5 nights. Pregnancy with confirmed BV → metronidazole oral or clindamycin (treatment reduces preterm-birth risk in some studies). Recurrent BV (≥ 4 episodes/year) → extended treatment course + suppressive metronidazole gel twice weekly for 4–6 months ± boric acid 600 mg vaginal capsules.
Belangrijk. Avoid alcohol with metronidazole and tinidazole (disulfiram-like reaction — flushing, palpitations, severe nausea). Confirm BV diagnosis by Amsel criteria or vaginal pH (raised > 4.5) where possible — empirical “yeast” treatment misses BV (40% of women self-diagnose incorrectly). Persistent or recurrent symptoms despite treatment warrant pelvic examination, full STI screening, and consideration of trichomoniasis (treated similarly with metronidazole) or atypical vaginal pathogens. BV is associated with increased acquisition risk for HIV, herpes, gonorrhoea, and chlamydia — STI screening recommended at diagnosis. Sexual partner treatment (male partners) does NOT reduce BV recurrence per evidence.
All MedsBase BV Treatment products ship from WHO-GMP gecertificeerde fabrikanten met discrete verpakking en vallen onder onze Reshipment Assurance Policy.